AffiliationDepartment of Surgery, Cork University Hospital, Wilton, Cork, Ireland., firstname.lastname@example.org
*Surgical Procedures, Operative
Wounds and Injuries/*immunology
MetadataShow full item record
CitationArch Surg. 2006 Nov;141(11):1132-40.
JournalArchives of surgery (Chicago, Ill. : 1960)
AbstractOBJECTIVES: To describe the profound alterations in host immunity that are produced by major surgery as demonstrated by experimental and clinical studies, and to evaluate the benefits of therapeutic strategies aimed at attenuating perioperative immune dysfunction. DATA SOURCES: A review of the English-language literature was conducted, incorporating searches of the MEDLINE, EMBASE, and Cochrane collaboration databases to identify laboratory and clinical studies investigating the cellular response to surgery. STUDY SELECTION: Original articles and case reports describing immune dysfunction secondary to surgical trauma were included. DATA EXTRACTION: The results were compiled to show outcomes of different studies and were compared. DATA SYNTHESIS: Current evidence indicates that the early systemic inflammatory response syndrome observed after major surgery that is characterized by proinflammatory cytokine release, microcirculatory disturbance, and cell-mediated immune dysfunction is followed by a compensatory anti-inflammatory response syndrome, which predisposes the patient to opportunistic infection, multiple organ dysfunction syndrome, and death. Because there are currently no effective treatment options for multiple organ dysfunction syndrome, measures to prevent its onset should be initiated at an early stage. Accumulating experimental evidence suggests that targeted therapeutic strategies involving immunomodulatory agents such as interferon gamma, granulocyte colony-stimulating factor, the prostaglandin E(2) antagonist, indomethacin, and pentoxifylline may be used for the treatment of systemic inflammatory response syndrome to prevent the onset of multiple organ dysfunction syndrome. CONCLUSIONS: Surgical trauma produces profound immunological dysfunction. Therapeutic strategies directed at restoring immune homeostasis should aim to redress the physiological proinflammatory-anti-inflammatory cell imbalance associated with major surgery.
- Inflammatory cytokines and cell response in surgery.
- Authors: Lin E, Calvano SE, Lowry SF
- Issue date: 2000 Feb
- Therapeutic immunomodulatory approaches for the control of systemic inflammatory response syndrome and the prevention of sepsis.
- Authors: Faist E, Kim C
- Issue date: 1998 May
- Role of biological modifiers regulating the immune response after trauma.
- Authors: Stahel PF, Smith WR, Moore EE
- Issue date: 2007 Dec
- Surgical trauma: hyperinflammation versus immunosuppression?
- Authors: Menger MD, Vollmar B
- Issue date: 2004 Nov
- Pathophysiology of polytrauma.
- Authors: Keel M, Trentz O
- Issue date: 2005 Jun